CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	4 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2014
Cash Flows Provided By (Used In) Operating Activities:
Net loss	$ (472,016)	$ (3,175,389)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Loss on expired option to acquire property	150,000
Depreciation and amortization		18,830
Amortization of debt discount		645,858
Amortization of deferred financing costs		25,556
Loss on derivative liability, net		541,397
Issuance of common stock to pay interest expense		3,669
Issuance of common stock for services		884,000
Changes in operating assets and liabilities:
(Increase) / decrease in accounts receivable	6,726	(33,598)
(Increase) / decrease in prepaid expenses and other assets	23,320	(12,664)
(Increase) in inventory		(62,805)
Increase in accounts payable and accrued expenses	20,516	33,075
Increase in accrued stock payable		122,500
Net cash used in operating activities	(271,454)	(1,009,571)
Cash Flows Provided By (Used In) Investing Activities:
Cash acquired in reverse merger with Promap	1,238
Purchase of property and equipment		(53,251)
Purchase of intangible assets		(38,200)
Purchase of option to acquire real estate	(150,000)
Net cash used in investing activities	(148,762)	(91,451)
Cash Flows Provided By (Used In) Financing Activities:
Purchase and cancellation of shares of common stock	(100,000)
Sales of common stock for cash	985,400
Proceeds from sale of warrants, net		400,000
Principal repayment on convertible notes payable		(3,178)
Proceeds from issuance of convertible notes payable, net of cash expenses		1,412,400
Deferred financing costs		(15,000)
Net cash provided by financing activities	885,400	1,794,222
Net Increase In Cash	465,184	693,200
Cash, beginning of period	0	427,436
Cash, end of period	465,184	1,120,636
SUPPLEMENTAL SCHEDULE OF CASH FLOW INFORMATION
Cash paid for interest		201,111
Supplemental Disclosure on non-cash financing activities:
Net liabilities acquired on recapitalization	2,944
Non-cash financing costs		100,000
Convertible notes payable settled in stock		485,000
Interest on convertible notes payable settled in stock		3,669
Warrants issued as payment for deferred financing costs		92,600
Beneficial conversion feature and warrants		$ 1,412,400